American Thoracic Society (ATS)

ATS Statement on Latest COVID-19 Policy Actions: Convalescent Plasma and Testing of Asymptomatic Patients

Newswise — Aug. 28, 2020 -- The American Thoracic Society is alarmed by two federal agency policy actions that may significantly impact our nation’s COVID-19 response. This week, the FDA issued an emergency use authorization (EUA) for the use of convalescent plasma to treat COVID-19 disease.  This action was taken despite a lack of adequate evidence demonstrating a clear benefit for most patients. As pulmonary and critical care clinicians and researchers who treat individuals with COVID-19, we are concerned that an EUA for convalescent plasma has the potential to put patients at risk. 

While convalescent plasma currently indicates promise as a treatment for some patients with COVID-19, more study is needed to determine who might benefit from treatment, when treatment is most effective and what risks might accrue to patients treated with it. Answers to these important questions will only be gained through rigorous clinical trials, ideally randomized controlled trials.  However, this EUA may discourage enrollment in clinical trials, may lead to use in low-volume settings where outcomes are generally worse, and may limit monitoring of adverse treatment outcomes.

We are also deeply concerned that the lack of transparency surrounding the EUA announcement has undermined the scientific credibility of the FDA. The ATS urges the FDA to publicly disclose the evidence base for issuing the EUA in the context of concerns raised by the scientific community, including the NIH leadership, to reassure the community and ensure public confidence in the FDA decision making process.

Secondly, the ATS is gravely concerned by the CDC’s revised guidance on COVID-19 testing. Public health evidence clearly indicates that asymptomatic individuals are important source vectors of SARS-CoV2 community transmission. Testing asymptomatic individuals who are close contacts of those known to have COVID-19 infection is an evidence-based public health intervention that slows infectious disease transmission, along with other critical interventions including contact tracing and isolation.  It is unclear what the scientific rationale is for changes that will lead to reduced testing of asymptomatic close contacts of COVID-19 positive individuals.

In addition, the revised CDC guidance was communicated to the public with insufficient clarification and little supporting evidence, leaving important interpretation to the lay press and general public, resulting in confusion for health professionals and the public. Changes in guidance without a clear scientific basis undermine trust in the CDC, our nation’s frontline public health agency, and has the potential to further hinder our COVID-19 response.

 The ATS recommends that the CDC restore the previous guidance on COVID testing and further, articulate a comprehensive plan for testing, contact tracing and isolation that minimizes community spread of SARS-CoV2. Finally, the ATS urges the Administration to adopt a comprehensive communication strategy that reinforces public confidence that decision-making on our pandemic response is driven by science and evidence-based public health practice, not politics.

 Share Via Twitter:
@atscommunity is deeply concerned by recent actions by @US_FDA and @CDCgov. Read our statement: WWW.THORACIC.ORG/covid/atscovid19-082820.pdf



Filters close

Showing results

110 of 6063
Newswise: Rush University Medical Center Mandates COVID-19 Vaccine for Workers
Released: 26-Jul-2021 5:25 PM EDT
Rush University Medical Center Mandates COVID-19 Vaccine for Workers
Rush University Medical Center

Rush University Medical Center will require all staff, contractors and volunteers to be fully vaccinated for COVID-19 by October 1.

Newswise: Scientists Model ‘True Prevalence’ of COVID-19 Throughout Pandemic
Released: 26-Jul-2021 3:15 PM EDT
Scientists Model ‘True Prevalence’ of COVID-19 Throughout Pandemic
University of Washington

Scientists have developed a statistical framework that incorporates key COVID-19 data to model the true prevalence of this disease in the U.S. Their approach projects that in the U.S. as many as 60% of COVID-19 cases went undetected as of March 7, 2021.

Newswise: OADN Joins Major Organizations  in Support of COVID-19 Vaccine Mandates for All Workers in Health and Long-Term Care
Released: 26-Jul-2021 3:05 PM EDT
OADN Joins Major Organizations in Support of COVID-19 Vaccine Mandates for All Workers in Health and Long-Term Care
Organization for Associate Degree Nursing (OADN)

Joint Statement in Support of COVID-19 Vaccine Mandates for All Workers in Health and Long-Term Care

Newswise: 271353_web.jpg
Released: 26-Jul-2021 2:00 PM EDT
Why Do Some People Get Severe COVID-19? The Nose May Know
Boston Children's Hospital

The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx.

Released: 26-Jul-2021 1:50 PM EDT
Early Antiviral Response in the Nose May Determine the Course of COVID-19
Broad Institute of MIT and Harvard

Researchers studied cells collected by nasal swabs at the moment of diagnosis for both mild and severe COVID-19 patients

23-Jul-2021 5:05 PM EDT
Research Suggests Ending Eviction Moratoriums Led to Spikes in COVID Cases and Deaths
UCLA Fielding School of Public Health

Research by a UCLA-led team has determined that the number of COVID-19 cases and the number of deaths from the disease both increased dramatically after states lifted eviction moratoriums that had been in place to protect people who were struggling to make rent payments during the pandemic.

Released: 26-Jul-2021 10:45 AM EDT
Emergency Department Visits Related to Opioid Overdoses Up Significantly During COVID-19 Pandemic
Mayo Clinic

Emergency department visit rates because of an opioid overdose increased by 28.5% across the U.S. in 2020, compared to 2018 and 2019, recent Mayo Clinic research finds. Emergency visits overall decreased by 14% last year, while visits because of an opioid overdose increased by 10.5%. The result: Opioid overdoses were responsible for 0.32 out of 100 visits, or 1 in every 313 visits, which is up from 0.25, or 1 in every 400 visits, the previous two years.

Newswise: Leading Experts Urge Health Care Workers to Accept COVID-19 Vaccinations ASAP
Released: 26-Jul-2021 10:30 AM EDT
Leading Experts Urge Health Care Workers to Accept COVID-19 Vaccinations ASAP
Florida Atlantic University

Leading experts address the clinical and public health challenges as well as ethical implications for health care workers to achieve high levels of vaccinations to protect themselves, their coworkers and the general public from COVID-19.

Released: 26-Jul-2021 10:30 AM EDT
Major Health Care Professional Organizations Call for COVID-19 Vaccine Mandates for All Health Workers
American Thoracic Society (ATS)

With COVID-19 case counts rising amid the spread of the Delta variant, more than 50 health care professional societies and organizations called for all health care employers to require their employees to be vaccinated against COVID-19 in a joint statement released today. These societies and organizations represent millions of workers throughout health and long-term care – from doctors and nurses to pharmacists and physician assistants, from public health workers and epidemiologists to long-term care, home care, and hospice workers.

Newswise:Video Embedded newswise-expert-panels-on-covid-19-pandemic-notable-excerpts-quotes-and-videos-available
VIDEO
Released: 26-Jul-2021 10:00 AM EDT
Newswise Expert Panels on COVID-19 Pandemic: Notable excerpts, quotes and videos available
Newswise

Newswise is hosting a series of Expert Panels discussion on unique aspects of the COVID-19 pandemic. This tip sheet includes some notable quotes from the panelists.


Showing results

110 of 6063

close
1.57693